Population pharmacokinetic modeling of ziprasidone in patients with schizophrenia from the CATIE study

Alette M. Wessels, Robert R. Bies, Bruce G. Pollock, Lon S. Schneider, Jeffrey A. Lieberman, Scott Stroup, Claire H. Li, Kim Coley, Margaret M. Kirshner, Stephen R. Marder

Research output: Contribution to journalArticle

18 Scopus citations
Original languageEnglish (US)
Pages (from-to)1587-1591
Number of pages5
JournalJournal of clinical pharmacology
Volume51
Issue number11
DOIs
StatePublished - Nov 1 2011

Keywords

  • population pharmacokinetics
  • schizophrenia
  • ziprasidone

ASJC Scopus subject areas

  • Pharmacology (medical)
  • Pharmacology

Cite this

Wessels, A. M., Bies, R. R., Pollock, B. G., Schneider, L. S., Lieberman, J. A., Stroup, S., Li, C. H., Coley, K., Kirshner, M. M., & Marder, S. R. (2011). Population pharmacokinetic modeling of ziprasidone in patients with schizophrenia from the CATIE study. Journal of clinical pharmacology, 51(11), 1587-1591. https://doi.org/10.1177/0091270010387604